Pharmaceutical preparations company · X0 · Revenue $839K · -9345.05% margin · -$66M FCF
The business is unprofitable at the operating level (-16292.84% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 98.7% YoY. Margins deteriorated 16146.5pp alongside, both lines moving the wrong way.
ROIC dropped from -63.93% to -73.19%, capital efficiency is deteriorating. Negative free cash flow of -$62M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$839K
▼ -98.7% YoY
Net Income (TTM)
-$75M
▼ -95.6% YoY
Op. Margin
-9345.05%
▼ -16146.5pp YoY
ROIC
-88.36%
▼ -9.3pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$66M
▲ +8.1% YoY
Op. Cash Flow (TTM)
-$66M
▲ +7.9% YoY
Net Debt
-$70M
Net Cash Position
Cash & Equiv.
$70M
3Y CAGR: -70.4%
Continue Research